Skip to main content

Table 3 Efficacy and effectiveness data for pneumococcal vaccines

From: Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

  PCV13 PPV23
  IPD
Age Group Efficacy Serotype Coverage Efficacy Serotype Coverage
18 - 39 93.9% [26]* 67.9% 74.0%*[9] 83.3%
40 - 49 75.4% 78.5%
50 - 59 63.4% 78.9%
60 - 69 63.9% 83.6%
70 - 79 71.4% 78.3%
80 - 89 74.8% 84.5%
≥ 90 76.2% 90.5%
  Inpatient CAP / Outpatient CAP (all cause)
Age Group Effectiveness Effectiveness
All 26.0%/6% [27, 28] 0%/0% [6, 9, 19]
  1. * = multiplication.